Context-dependent peptide recognition shapes tyrosine kinase substrate specificity beyond consensus motifs

preprint OA: closed
Full text JSON View at publisher
Full text 1,966 characters · extracted from oa-doi-fallback · click to expand
ABSTRACT Protein tyrosine kinases (PTKs) regulate cellular biochemistry by phosphorylating tyrosine residues that alter protein function; their substrate preferences define the topology of signaling cascades. Previous studies of PTKs have mapped their average preferences for amino acids surrounding phosphorylation sites, but their ability to discriminate between highly similar substrate sequences (i.e., their sensitivity to minor changes in sequence within different regions of a substrate, and the sequence-dependent nature of this sensitivity) remains poorly understood. Here, we use a genetically encoded biosensor for PTK activity to examine the influence of local sequence context on substrate specificity. Across five well-studied PTKs, we identified amino acid substitutions within consensus substrates that could enhance selectivity for one PTK over others, confer sensitivity to substrate length, or improve PTK compatibility beyond the consensus. These effects were not predicted by classical specificity maps or advanced molecular modeling tools. Using a dual-selection screen that incorporates decoy substrates, we found additional sequence-diverse substrates with unexpectedly orthogonal PTK compatibilities. Our findings show how context-specific sequence features alter PTK substrate specificity far beyond what might be expected from classical consensus models and establish an experimental framework for defining the limits of substrate overlap between closely related kinases. Competing Interest Statement N.O., J.M.K., and J.M.F are employees of and hold equity in Think Bioscience, which develops small-molecule therapeutics. Think Bioscience has licensed intellectual property related to the biosensors described in this paper from the University of Colorado. The company is exploring many drug targets, including protein tyrosine kinases (PTKs), though, at present, they are not actively pursuing any of the PTKs listed in this publication.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00